This invention relates to salt forms of the compound N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N′-[3-(1-methyl-
1
H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide, an inhibitor of tyrosine kinases, in particular the receptor tyrosine kinase MET, that are useful in the treatment of cellular proliferative diseases, for example cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. in particular, the invention relates to the sodium salt of N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N′-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide.
这项发明涉及化合物N-[(2R)-1,4-二氧杂
环戊烷-2-基甲基]-N-甲基-N′-[3-(1-甲基-1H-
吡唑-4-基)-5-氧代-5H-苯并[4,5]环庚[1,2-b]
吡啶-7-基]磺酰胺的盐形式,该化合物是一种
酪氨酸激酶
抑制剂,特别是受体
酪氨酸激酶MET的
抑制剂,对于治疗细胞增殖性疾病,例如癌症、增生、再狭窄、心肌肥大、免疫紊乱和炎症等疾病具有用处。特别是,该发明涉及N-[(2R)-1,4-二氧杂
环戊烷-2-基甲基]-N-甲基-N′-[3-(1-甲基-1H-
吡唑-4-基)-5-氧代-5H-苯并[4,5]环庚[1,2-b]
吡啶-7-基]磺酰胺的钠盐。